{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T17:36:01Z","timestamp":1773423361299,"version":"3.50.1"},"reference-count":108,"publisher":"SAGE Publications","issue":"2","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Annals of Clinical Psychiatry"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.12788\/acp.0109","type":"journal-article","created":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T17:16:59Z","timestamp":1682961419000},"page":"118-130","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":8,"title":["Covid-19 and Catatonia: Prevalence, Challenges, Pathophysiology, and Treatment"],"prefix":"10.1177","volume":"35","author":[{"given":"Joan","family":"Oh","sequence":"first","affiliation":[{"name":"Cooper Medical School of Rowan University Camden, New Jersey, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Puneet Chawla","family":"Sahota","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Behavioral Health Cooper University Health Care Cooper Medical School of Rowan University Camden, New Jersey, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tarannum","family":"Mohammadi","sequence":"additional","affiliation":[{"name":"Drexel University College of Medicine Philadelphia, Pennsylvania, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Basant K.","family":"Pradhan","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Behavioral Health Cooper University Health Care Cooper Medical School of Rowan University Camden, New Jersey, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maju Mathew","family":"Koola","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Behavioral Health Cooper University Health Care Cooper Medical School of Rowan University Camden, New Jersey, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2023,3]]},"reference":[{"key":"e_1_3_2_2_2","unstructured":"World Health Organization. WHO Director-General's opening remarks at the media briefing on COVID-19 - 11 March 2020. Accessed February 27 2023. https:\/\/www.who.int\/director-general\/speeches\/detail\/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19\u201411-march-2020"},{"key":"e_1_3_2_3_2","unstructured":"World Health Organization. WHO Coronavirus Disease (COVID-19) Dashboard. Accessed February 27 2023. https:\/\/covidl9.who.int\/"},{"issue":"4","key":"e_1_3_2_4_2","article-title":"SARS, MERS and COVID-19: clinical manifestations and organ-system complications: a mini review","volume":"78","author":"Harb JG","year":"2020","unstructured":"HarbJG, NoureldineHA, ChedidG, et al. SARS, MERS and COVID-19: clinical manifestations and organ-system complications: a mini review. Pathog Dis. 2020; 78 (4):ftaa033.","journal-title":"Pathog Dis"},{"key":"e_1_3_2_5_2","doi-asserted-by":"crossref","first-page":"577","DOI":"10.3389\/fpsyg.2021.577529","article-title":"Neuropsychiatric and cognitive sequelae of COVID-19","volume":"12","author":"Kumar S","year":"2021","unstructured":"KumarS, VeldhuisA, MalhotraT. Neuropsychiatric and cognitive sequelae of COVID-19. Front Psychol. 2021;12:577\u2013529.","journal-title":"Front Psychol"},{"issue":"5","key":"e_1_3_2_6_2","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1001\/jamapsychiatry.2021.0109","article-title":"Gemelli Against COVID-19 Post-Acute Care Study Group. Posttraumatic stress disorder in patients after severe COVID-19 infection","volume":"78","author":"Janiri D","year":"2021","unstructured":"JaniriD, CarfiA, KotzalidisGD, et al; Gemelli Against COVID-19 Post-Acute Care Study Group. Posttraumatic stress disorder in patients after severe COVID-19 infection. JAMA Psychiatry. 2021;78 (5):567\u2013569.","journal-title":"JAMA Psychiatry"},{"issue":"9","key":"e_1_3_2_7_2","doi-asserted-by":"crossref","first-page":"3059","DOI":"10.1007\/s00415-021-10406-y","article-title":"Neurological symptoms, manifestations, and complications associated with severe acute respiratory syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus disease 19 (COVID-19)","volume":"268","author":"Harapan BN","year":"2021","unstructured":"HarapanBN, YooHJ. Neurological symptoms, manifestations, and complications associated with severe acute respiratory syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus disease 19 (COVID-19). J Neurol. 2021; 268 (9):3059\u20133071.","journal-title":"J Neurol"},{"issue":"4","key":"e_1_3_2_8_2","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1002\/jmv.26720","article-title":"Cellular mechanisms underlying neurological\/neuropsychiatric manifestations of COVID-19","volume":"93","author":"Bodnar B","year":"2021","unstructured":"BodnarB, PatelK, HoW, et al. Cellular mechanisms underlying neurological\/neuropsychiatric manifestations of COVID-19. J Med Virol. 2021;93 (4): 1983\u20131998.","journal-title":"J Med Virol"},{"issue":"6","key":"e_1_3_2_9_2","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.jaclp.2021.04.003","article-title":"COVID-19 and catatonia: a case series and systematic review of existing literature","volume":"62","author":"Schemer NS","year":"2021","unstructured":"SchemerNS, SmithAK, WohlleberM, et al. COVID-19 and catatonia: a case series and systematic review of existing literature. J Acad Consult-Liaison Psychiatry. 2021; 62 (6):645\u2013656.","journal-title":"J Acad Consult-Liaison Psychiatry"},{"key":"e_1_3_2_10_2","article-title":"Die Katatonie: oder das Spannungsirresein, eine klinische Form psychischer Krankheit \/ von Karl Kahlbaum, I. Heft","author":"Kahlbaum KL.","year":"1874","unstructured":"KahlbaumKL. Die Katatonie: oder das Spannungsirresein, eine klinische Form psychischer Krankheit \/ von Karl Kahlbaum, I. Heft. Klinische Abhandlungen \u00fcber Psychische Krankheiten, I Heft. Hirschbaum; 1874.","journal-title":"Klinische Abhandlungen \u00fcber Psychische Krankheiten"},{"issue":"5","key":"e_1_3_2_11_2","doi-asserted-by":"crossref","first-page":"el9","DOI":"10.1016\/j.biopsych.2020.07.001","article-title":"COVID-19 catatonia - would we even know?","volume":"88","author":"Cooper JJ","year":"2020","unstructured":"CooperJJ, RossDA. COVID-19 catatonia - would we even know? Biol Psychiatry. 2020;88 (5):el9\u2013e21.","journal-title":"Biol Psychiatry"},{"issue":"2","key":"e_1_3_2_12_2","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1093\/schbul\/sbp059","article-title":"Catatonia is not schizophrenia: Kraepelin's error and the need to recognize catatonia as an independent syndrome in medical nomenclature","volume":"36","author":"Fink M","year":"2010","unstructured":"FinkM, ShorterE, TaylorMA. Catatonia is not schizophrenia: Kraepelin's error and the need to recognize catatonia as an independent syndrome in medical nomenclature. Schizophr Bull. 2010; 36 (2):314\u2013320.","journal-title":"Schizophr Bull"},{"key":"e_1_3_2_13_2","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.schres.2013.04.034","article-title":"Catatonia in DSM-5","volume":"150","author":"Tandon R","year":"2013","unstructured":"TandonR, HeckersS, BustilloJ, et al. Catatonia in DSM-5. Schizophr Res. 2013;150 (l):26\u201330.","journal-title":"Schizophr Res"},{"issue":"4","key":"e_1_3_2_14_2","doi-asserted-by":"crossref","first-page":"391","DOI":"10.5498\/wjp.v6.i4.391","article-title":"Catatonia: our current understanding of its diagnosis, treatment and pathophysiology","volume":"6","author":"Rasmussen SA","year":"2016","unstructured":"RasmussenSA, MazurekMF, RosebushPI. Catatonia: our current understanding of its diagnosis, treatment and pathophysiology. World J Psychiatry. 2016; 6 (4):391\u2013398.","journal-title":"World J Psychiatry"},{"issue":"11","key":"e_1_3_2_15_2","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1001\/archgenpsychiatry.2009.141","article-title":"The catatonia syndrome: forgotten but not gone","volume":"66","author":"Fink M","year":"2009","unstructured":"FinkM, TaylorMA. The catatonia syndrome: forgotten but not gone. Arch Gen Psychiatry. 2009;66 (11): 1173\u20131177.","journal-title":"Arch Gen Psychiatry"},{"issue":"6","key":"e_1_3_2_16_2","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1176\/ajp.2007.164.6.870","article-title":"Neuroleptic malignant syndrome","volume":"164","author":"Strawn","year":"2007","unstructured":"StrawnJR, KeckPEJr, CaroffSN. Neuroleptic malignant syndrome. Am J Psychiatry. 2007; 164 (6): 870\u2013876.","journal-title":"Am J Psychiatry"},{"issue":"4","key":"e_1_3_2_17_2","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.psym.2018.04.001","article-title":"The probability that catatonia in the hospital has a medical cause and the relative proportions of its causes: a systematic review","volume":"59","author":"Oldham MA.","year":"2018","unstructured":"OldhamMA. The probability that catatonia in the hospital has a medical cause and the relative proportions of its causes: a systematic review. Psychosomatics. 2018; 59 (4):333\u2013340.","journal-title":"Psychosomatics"},{"issue":"4","key":"e_1_3_2_18_2","first-page":"41","article-title":"The pharmacotherapy of catatonia","volume":"17","author":"Carroll BT","year":"2010","unstructured":"CarrollBT, LeeJ, AppianiF, et al. The pharmacotherapy of catatonia. Primary Psychiatry. 2010; 17 (4):41\u201347.","journal-title":"Primary Psychiatry"},{"issue":"7","key":"e_1_3_2_19_2","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/S2215-0366(18)30474-7","article-title":"Structure and neural mechanisms of catatonia","volume":"6","author":"Walther S","year":"2019","unstructured":"WaltherS, StegmayerK, WilsonJE, et al. Structure and neural mechanisms of catatonia. Lancet Psychiatry. 2019; 6 (7):610\u2013619.","journal-title":"Lancet Psychiatry"},{"issue":"7","key":"e_1_3_2_20_2","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/S2215-0366(19)30190-7","article-title":"Catatonia and the immune system: a review","volume":"6","author":"Rogers JP","year":"2019","unstructured":"RogersJP, PollakTA, BlackmanG, et al. Catatonia and the immune system: a review. Lancet Psychiatry. 2019; 6 (7):620\u2013630.","journal-title":"Lancet Psychiatry"},{"issue":"4","key":"e_1_3_2_21_2","doi-asserted-by":"crossref","first-page":"570","DOI":"10.3390\/neurolint13040057","article-title":"Catatonia: clinical overview of the diagnosis, treatment, and clinical challenges","volume":"13","author":"Edinoff AN","year":"2021","unstructured":"EdinoffAN, KaufmanSE, HollierJW, et al. Catatonia: clinical overview of the diagnosis, treatment, and clinical challenges. Neurol Int. 2021; 13 (4):570\u2013586.","journal-title":"Neurol Int"},{"issue":"2","key":"e_1_3_2_22_2","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1111\/j.1600-0447.1996.tb09814.x","article-title":"Catatonia. I. Rating scale and standardized examination","volume":"93","author":"Bush G","year":"1996","unstructured":"BushG, FinkM, PetridesG, et al. Catatonia. I. Rating scale and standardized examination. Acta Psychiatr Scand. 1996; 93 (2):129\u2013136.","journal-title":"Acta Psychiatr Scand"},{"issue":"9","key":"e_1_3_2_23_2","first-page":"52","article-title":"The detection and measurement of catatonia","volume":"4","author":"Kirkhart R","year":"2007","unstructured":"KirkhartR, AhujaN, LeeJW, et al. The detection and measurement of catatonia. Psychiatry (Edgmont). 2007; 4 (9):52\u201356.","journal-title":"Psychiatry (Edgmont)"},{"issue":"3","key":"e_1_3_2_24_2","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1097\/YCT.0000000000000838","article-title":"Catatonia after COVID-19: a case series","volume":"38","author":"Nikayin S","year":"2022","unstructured":"NikayinS, ChaffkinJ, OstroffRB. Catatonia after COVID-19: a case series. J ECT. 2022;38 (3):143\u2013144","journal-title":"J ECT"},{"key":"e_1_3_2_25_2","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2021.696347","article-title":"Postinfectious COVID-19 catatonia: a report of two cases","volume":"12","author":"Torrico T","year":"2021","unstructured":"TorricoT, KiongT, AssumpcaoC.D., et al. Postinfectious COVID-19 catatonia: a report of two cases. Front Psychiatry. 2021;12:696347.","journal-title":"Front Psychiatry"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1192\/bjb.2022.30"},{"issue":"5","key":"e_1_3_2_27_2","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.psym.2020.05.021","article-title":"A case of catatonia in a man with COVID-19","volume":"61","author":"Caan MP","year":"2020","unstructured":"CaanMP, LimCT, HowardM. A case of catatonia in a man with COVID-19. Psychosomatics. 2020; 61 (5):556\u2013560.","journal-title":"Psychosomatics"},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbi.2020.08.007"},{"issue":"1","key":"e_1_3_2_29_2","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1186\/s12974-021-02293-x","article-title":"Molecular mimicry of NMDA receptors may contribute to neuropsychiatric symptoms in severe COVID-19 cases","volume":"18","author":"Vasilevska V","year":"2021","unstructured":"VasilevskaV, GuestPC, BernsteinHG, et al. Molecular mimicry of NMDA receptors may contribute to neuropsychiatric symptoms in severe COVID-19 cases. J Neuroinflamm. 2021;18 (1):245.","journal-title":"J Neuroinflamm"},{"issue":"6","key":"e_1_3_2_30_2","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2020-240550","article-title":"Catatonic syndrome as the presentation of encephalitis in association with COVID-19","volume":"14","author":"Vazquez-Guevara D","year":"2021","unstructured":"Vazquez-GuevaraD, Badial-OchoaS, Caceres-RajoKM, et al. Catatonic syndrome as the presentation of encephalitis in association with COVID-19. BMJ Case Rep. 2021; 14 (6):e240550.","journal-title":"BMJ Case Rep"},{"issue":"7","key":"e_1_3_2_31_2","article-title":"A case of fatal catatonia in a COVID-19 patient","volume":"13","author":"Kwon HJ","year":"2021","unstructured":"KwonHJ, PatelKH, RamirezM, et al. A case of fatal catatonia in a COVID-19 patient. Cureus. 2021; 13 (7):el6529.","journal-title":"Cureus"},{"key":"e_1_3_2_32_2","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.ajp.2021.102761","article-title":"Association between COVID-19 and catatonia manifestation in two adolescents in Central Asia: incidental findings or cause for alarm?","volume":"63","author":"Kopishinskaia S","year":"2021","unstructured":"KopishinskaiaS, CummingP, KarpukhinaS, et al. Association between COVID-19 and catatonia manifestation in two adolescents in Central Asia: incidental findings or cause for alarm? Asian J Psychiatr. 2021;63:102\u2013761.","journal-title":"Asian J Psychiatr"},{"key":"e_1_3_2_33_2","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2021.764197","article-title":"Acute psychosis due to anti-N-methyl-D-aspartate receptor encephalitis following COVID-19 vaccination: a case report","volume":"12","author":"Flannery P","year":"2021","unstructured":"FlanneryP, YangI, KeyvaniM, et al. Acute psychosis due to anti-N-methyl-D-aspartate receptor encephalitis following COVID-19 vaccination: a case report. Front Neurol. 2021;12:764197.","journal-title":"Front Neurol"},{"key":"e_1_3_2_34_2","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajp.2022.103004","article-title":"Concurrent catatonia and COVID-19 infection - an experiential account of challenges and management of cases from a tertiary care psychiatric hospital in India","volume":"69","author":"Sakhardande KA","year":"2022","unstructured":"SakhardandeKA, PathakH, MahadevanJ, et al. Concurrent catatonia and COVID-19 infection - an experiential account of challenges and management of cases from a tertiary care psychiatric hospital in India. Asian J Psychiatr. 2022;69:103004.","journal-title":"Asian J Psychiatr"},{"issue":"1","key":"e_1_3_2_35_2","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.psym.2020.09.002","article-title":"A case of concurrent delirium and catatonia in a woman with Coronavirus disease 2019","volume":"62","author":"Amouri J","year":"2021","unstructured":"AmouriJ, AndrewsPS, HeckersS, et al. A case of concurrent delirium and catatonia in a woman with Coronavirus disease 2019. J Acad Consult Liaison Psychiatry. 2021; 62 (1):109\u2013114.","journal-title":"J Acad Consult Liaison Psychiatry"},{"issue":"10","key":"e_1_3_2_36_2","article-title":"New-onset catatonia and delirium in a COVID-positive patient","volume":"13","author":"Kaur G","year":"2021","unstructured":"KaurG, KhavarianZ, BasithSA, et al. New-onset catatonia and delirium in a COVID-positive patient. Cureus. 2021;13 (10):el8422.","journal-title":"Cureus"},{"issue":"3","key":"e_1_3_2_37_2","article-title":"Excited catatonia - a delayed neuropsychiatric complication of COVID-19 infection","volume":"13","author":"Zain SM","year":"2021","unstructured":"ZainSM, MuthukanagarajP, RahmanN. Excited catatonia - a delayed neuropsychiatric complication of COVID-19 infection. Cureus. 2021;13 (3):el3891.","journal-title":"Cureus"},{"key":"e_1_3_2_38_2","first-page":"63","article-title":"(PO-172) COVID-19 catatonia: a review and update after one year","author":"Blum AW","year":"2022","unstructured":"BlumAW, LeoH, IhleEC, et al. (PO-172) COVID-19 catatonia: a review and update after one year. J Acad Consult Liaison Psychiatry. 2022;63:S79.","journal-title":"J Acad Consult Liaison Psychiatry"},{"issue":"6","key":"e_1_3_2_39_2","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1176\/appi.ajp.2020.20081236","article-title":"Autoimmune encephalitis presenting with malignant catatonia in a 40-year-old male patient with COVID-19","volume":"178","author":"Mulder J","year":"2021","unstructured":"MulderJ, FeresiadouA, F\u00e4llmarD, et al. Autoimmune encephalitis presenting with malignant catatonia in a 40-year-old male patient with COVID-19. Am J Psychiatry. 2021; 178 (6):485\u2013489.","journal-title":"Am J Psychiatry"},{"issue":"5","key":"e_1_3_2_40_2","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.psym.2020.05.025","article-title":"Clozapine toxicity in the setting of COVID-19","volume":"61","author":"Dotson S","year":"2020","unstructured":"DotsonS, HartvigsenN, WesnerT, et al. Clozapine toxicity in the setting of COVID-19. Psychos omatics. 2020; 61 (5):577\u2013578.","journal-title":"Psychos omatics"},{"key":"e_1_3_2_41_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.schres.2017.03.045"},{"issue":"2","key":"e_1_3_2_42_2","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/pcn.13174","article-title":"Exacerbation of psychosis accompanied by seizure and catatonia in a patient with COVID-19: a case report","volume":"75","author":"Zandifar A","year":"2021","unstructured":"ZandifarA, BadrfamR. Exacerbation of psychosis accompanied by seizure and catatonia in a patient with COVID-19: a case report. Psychiatry Clin Neurosci. 2021; 75 (2):63\u201364.","journal-title":"Psychiatry Clin Neurosci"},{"issue":"1","key":"e_1_3_2_43_2","doi-asserted-by":"crossref","DOI":"10.1186\/s12888-020-02978-2","article-title":"COVID-19 related lockdown: a trigger from the pre-melancholic phase to catatonia and depression, a case report of a 59-year-old man","volume":"20","author":"Sarli G","year":"2020","unstructured":"SarliG, PolidoriL, LesterD, et al. COVID-19 related lockdown: a trigger from the pre-melancholic phase to catatonia and depression, a case report of a 59-year-old man. BMC Psychiatry. 2020;20 (1):558.","journal-title":"BMC Psychiatry"},{"issue":"1","key":"e_1_3_2_44_2","first-page":"2010","article-title":"COVID-19 pandemic-induced late-onset psychotic depression with catatonia","volume":"23","author":"Lynch A","year":"2021","unstructured":"LynchA, BastiampillaiT. COVID-19 pandemic-induced late-onset psychotic depression with catatonia. Prim Care Companion CNS Disord. 2021;23 (1): 2010\u20132827.","journal-title":"Prim Care Companion CNS Disord"},{"issue":"3","key":"e_1_3_2_45_2","first-page":"137","article-title":"Mental health outcomes of the COVID-19 pandemic","volume":"55","author":"Talevi D","year":"2020","unstructured":"TaleviD, SocciV, CaraiM, et al. Mental health outcomes of the COVID-19 pandemic. Riv Psichiatr. 2020; 55 (3):137\u2013144.","journal-title":"Riv Psichiatr"},{"key":"e_1_3_2_46_2","first-page":"100","article-title":"Pandemics and pre-existing mental illness: a systematic review and metaanalysis","volume":"10","author":"Neelam K","year":"2021","unstructured":"NeelamK, Dudduy AnyimN, et al. Pandemics and pre-existing mental illness: a systematic review and metaanalysis. Brain Behav Immun Health. 2021;10:100\u2013177.","journal-title":"Brain Behav Immun Health"},{"issue":"5","key":"e_1_3_2_47_2","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1097\/NMD.0000000000001300","article-title":"Should catatonia be conceptualized as a pathological response to trauma?","volume":"209","author":"Biles TR","year":"2021","unstructured":"BilesTR, AnemG, YoussefNA. Should catatonia be conceptualized as a pathological response to trauma? J NervMent Dis. 2021; 209 (5):320\u2013323.","journal-title":"J NervMent Dis"},{"issue":"6","key":"e_1_3_2_48_2","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.jaclp.2021.08.009","article-title":"Akinetic mutism and Coronavirus disease 2019: a narrative review","volume":"62","author":"Fusunyan M","year":"2021","unstructured":"FusunyanM, PraschanN, FricchioneG, et al. Akinetic mutism and Coronavirus disease 2019: a narrative review. J Acad Consult Liaison Psychiatry. 2021;62 (6): 625\u2013633.","journal-title":"J Acad Consult Liaison Psychiatry"},{"issue":"4","key":"e_1_3_2_49_2","doi-asserted-by":"crossref","first-page":"576","DOI":"10.3390\/bs5040576","article-title":"The syndrome of catatonia","volume":"5","author":"Wilcox JA","year":"2015","unstructured":"WilcoxJA, DuffyPR. The syndrome of catatonia. Behav Sci (Basel). 2015; 5 (4):576\u2013588.","journal-title":"Behav Sci (Basel)"},{"issue":"4","key":"e_1_3_2_50_2","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1097\/00001199-200507000-00009","article-title":"Disorders of diminished motivation","volume":"20","author":"Marin RS","year":"2005","unstructured":"MarinRS, WilkoszPA. Disorders of diminished motivation. J Head Trauma Rehabil. 2005; 20 (4):377\u2013388.","journal-title":"J Head Trauma Rehabil"},{"issue":"2","key":"e_1_3_2_51_2","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1002\/mds.1071","article-title":"Catatonia or abulia? A difficult differential diagnosis","volume":"16","author":"Muqit MM","year":"2001","unstructured":"MuqitMM, RakshiJS, ShakirRA, et al. Catatonia or abulia? A difficult differential diagnosis. Move Disord. 2001; 16 (2):360\u2013362.","journal-title":"Move Disord"},{"issue":"3","key":"e_1_3_2_52_2","article-title":"Pulmonary embolism confounded with COVID-19 suspicion in a catatonic patient presenting to anesthesia for ECT: a case report","volume":"71","author":"Naik BN","year":"2021","unstructured":"NaikBN, SinghN, AdityaAS, et al. Pulmonary embolism confounded with COVID-19 suspicion in a catatonic patient presenting to anesthesia for ECT: a case report. Braz J Anesthesiol.2021; 71 (3):292-294.","journal-title":"Braz J Anesthesiol"},{"issue":"30","key":"e_1_3_2_53_2","doi-asserted-by":"crossref","first-page":"3795","DOI":"10.1021\/acschemneuro.1c00477","article-title":"Mechanism of anosmia caused by symptoms of COVID-19 and emerging treatments","volume":"12","author":"Najafloo R","year":"2021","unstructured":"NajaflooR, MajidiJ, AsghariA, et al. Mechanism of anosmia caused by symptoms of COVID-19 and emerging treatments. ACS Chem Neurosci. 2021; 12 (30):3795\u20133805.","journal-title":"ACS Chem Neurosci"},{"issue":"3","key":"e_1_3_2_54_2","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.schres.2012.02.012","article-title":"Medical and developmental risk factors of catatonia in children and adolescents: a prospective case-control study","volume":"137","author":"Consoli A","year":"2012","unstructured":"ConsoliA, RaffinM, LaurentC, et al. Medical and developmental risk factors of catatonia in children and adolescents: a prospective case-control study. Schizophr Res. 2012;137 (l-3):151\u2013158.","journal-title":"Schizophr Res"},{"key":"e_1_3_2_55_2","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.pnpbp.2017.05.013","article-title":"Prevalence and characteristics of catatonia on admission to an acute geriatric psychiatry ward","volume":"78","author":"Cuevas- Esteban J","year":"2017","unstructured":"Cuevas- EstebanJ, Iglesias-Gonz\u00e1lezM, Rubio-ValeraM, et al. Prevalence and characteristics of catatonia on admission to an acute geriatric psychiatry ward. Prog Neuropsychopharmacol Biol Psychiatry. 2017;78:27\u201333.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"2","key":"e_1_3_2_56_2","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1176\/appi.neuropsych.11060120","article-title":"Catatonic disorder due to a general medical or psychiatric condition","volume":"24","author":"Smith JH","year":"2012","unstructured":"SmithJH, SmithVD, PhilbrickKL, et al. Catatonic disorder due to a general medical or psychiatric condition. J Neuropsychiatry Clin Neurosci. 2012;24 (2): 198\u2013207.","journal-title":"J Neuropsychiatry Clin Neurosci"},{"issue":"1","key":"e_1_3_2_57_2","article-title":"A case of catatonia in the aftermath of the COVID-19 pandemic: does autism spectrum matter?","volume":"20","author":"Dell'Osso L","year":"2021","unstructured":"Dell'OssoL, AmatoriG, GesiC, et al. A case of catatonia in the aftermath of the COVID-19 pandemic: does autism spectrum matter? Ann Gen Psychiatry. 2021;20 (1):54.","journal-title":"Ann Gen Psychiatry"},{"key":"e_1_3_2_58_2","doi-asserted-by":"publisher","DOI":"10.1192\/j.eurpsy.2021.2259"},{"issue":"4","key":"e_1_3_2_59_2","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1136\/jnnp.67.4.445","article-title":"Decreased density of GABA-A receptors in the left sensorimotor cortex in akinetic catatonia: investigation of in vivo benzodiazepine receptor binding","volume":"67","author":"Northoff G","year":"1999","unstructured":"NorthoffG, SteinkeR, CzcervenkaC, et al. Decreased density of GABA-A receptors in the left sensorimotor cortex in akinetic catatonia: investigation of in vivo benzodiazepine receptor binding. J Neurol Neurosurg Psychiatry. 1999; 67 (4):445\u2013450.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"e_1_3_2_60_2","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0074-7742(05)72010-9","article-title":"Shared susceptibility region on chromosome 15 between autism and catatonia","volume":"72","author":"Chagnon YC.","year":"2006","unstructured":"ChagnonYC. Shared susceptibility region on chromosome 15 between autism and catatonia. Int Rev Neurobiol. 2006;72:165\u2013178.","journal-title":"Int Rev Neurobiol"},{"issue":"3","key":"e_1_3_2_61_2","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1111\/1469-7610.00451","article-title":"Infantile autism and associated autosomal chromosome abnormalities: a register-based study and a literature survey","volume":"40","author":"Lauritsen M","year":"1999","unstructured":"LauritsenM, MorsO, MortensenPB, et al. Infantile autism and associated autosomal chromosome abnormalities: a register-based study and a literature survey. J Child Psychol Psychiatry. 1999;40 (3): 335\u2013345.","journal-title":"J Child Psychol Psychiatry"},{"key":"e_1_3_2_62_2","doi-asserted-by":"crossref","unstructured":"BeyerstedtS CasaroEB Rangel \u00c9B. COVID-19: angiotensin-converting enzyme 2 (ACE2) expression and tissue susceptibility to SARS-CoV-2 infection. Eur J Clin Microbiol Infect Dis. 2021; 40 (5):905\u2013919.","DOI":"10.1007\/s10096-020-04138-6"},{"key":"e_1_3_2_63_2","article-title":"Nervous system involvement after infection with COVID-19 and other Coronavirus es","volume":"87","author":"Wu Y","year":"2020","unstructured":"WuY, XuX, ChenZ, et al. Nervous system involvement after infection with COVID-19 and other Coronavirus es. Brain Behav Immun. 2020;87:18-22.","journal-title":"Brain Behav Immun"},{"issue":"6","key":"e_1_3_2_64_2","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1001\/jamapsychiatry.2021.0500","article-title":"How COVID-19 affects the brain","volume":"78","author":"Boldrini M","year":"2021","unstructured":"BoldriniM, CanollPD, KleinRS. How COVID-19 affects the brain. JAMA Psychiatry. 2021; 78 (6):682\u2013683.","journal-title":"JAMA Psychiatry"},{"issue":"4","key":"e_1_3_2_65_2","article-title":"Inflammatory neuropsychiatric disorders and COVID-19 neuro-inflammation","volume":"33","author":"Tang SW","year":"2021","unstructured":"TangSW, HelmesteD, LeonardB. Inflammatory neuropsychiatric disorders and COVID-19 neuro-inflammation. Acta Neuropsychiatr. 2021;33 (4): 165-177.","journal-title":"Acta Neuropsychiatr"},{"key":"e_1_3_2_66_2","doi-asserted-by":"crossref","DOI":"10.3389\/fnhum.2021.656313","article-title":"Neuropsychiatric symptoms of COVID-19 explained by SARS-CoV-2 proteins\u2019 mimicry of human protein interactions","volume":"15","author":"Yapici-Eser H","year":"2021","unstructured":"Yapici-EserH, KorogluYE, Oztop-CakmakO, et al. Neuropsychiatric symptoms of COVID-19 explained by SARS-CoV-2 proteins\u2019 mimicry of human protein interactions. Front Hum Neurosci. 2021;15:656313.","journal-title":"Front Hum Neurosci"},{"issue":"3","key":"e_1_3_2_67_2","article-title":"A case and proposed mechanism of catatonia during the post-acute phase of severe acute respiratory syndrome Coronavirus 2 infection","volume":"24","author":"Spiegel","year":"2022","unstructured":"SpiegelDR, KisteneffA, FidelisW, et al. A case and proposed mechanism of catatonia during the post-acute phase of severe acute respiratory syndrome Coronavirus 2 infection. Prim Care Companion CNS Disord. 2022;24 (3):21cr03233.","journal-title":"Prim Care Companion CNS Disord"},{"key":"e_1_3_2_68_2","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.psychres.2021.113710","article-title":"May confusion be a misleading initial clinical presentation of COVID-19 in individuals with mood disorders?","volume":"297","author":"Vorspan F","year":"2021","unstructured":"VorspanF, AmarsyR, EtainB. May confusion be a misleading initial clinical presentation of COVID-19 in individuals with mood disorders? Psychiatry Res. 2021; 297:113\u2013710.","journal-title":"Psychiatry Res"},{"key":"e_1_3_2_69_2","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.micpath.2021.104799","article-title":"The proinflammatory cytokines in COVID-19 pathogenesis: what goeswrong?","volume":"153","author":"Darif D","year":"2021","unstructured":"DarifD, HammiI, KihelA, et al. The proinflammatory cytokines in COVID-19 pathogenesis: what goeswrong? Microb Pathog. 2021;153:104\u2013799.","journal-title":"Microb Pathog"},{"issue":"10","key":"e_1_3_2_70_2","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1017\/S0033291720001853","article-title":"Brain imaging in catatonia: systematic review and directions for future research","volume":"50","author":"Haroche A","year":"2020","unstructured":"HarocheA, RogersJ, PlazeM, et al. Brain imaging in catatonia: systematic review and directions for future research. Psychol Med. 2020; 50 (10):1585\u20131597.","journal-title":"Psychol Med"},{"issue":"2","key":"e_1_3_2_71_2","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1111\/j.1600-0447.1996.tb09815.x","article-title":"Treatment with lorazepam and electroconvulsive therapy","volume":"93","author":"Bush G","year":"1996","unstructured":"BushG, FinkM, PetridesG, et al. CatatoniaII. Treatment with lorazepam and electroconvulsive therapy. Acta Psychiatr Scand. 1996; 93 (2):137\u2013143.","journal-title":"Acta Psychiatr Scand"},{"key":"e_1_3_2_72_2","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2014.00181"},{"issue":"4","key":"e_1_3_2_73_2","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1176\/jnp.2009.21.4.371","article-title":"Catatonia: clinical aspects and neurobiological correlates","volume":"21","author":"Daniels J.","year":"2009","unstructured":"DanielsJ. Catatonia: clinical aspects and neurobiological correlates. J Neuropsychiatry Clin Neurosci. 2009; 21 (4):371\u2013380.","journal-title":"J Neuropsychiatry Clin Neurosci"},{"issue":"4","key":"e_1_3_2_74_2","doi-asserted-by":"crossref","first-page":"345","DOI":"10.2190\/X0FF-VU7G-QQP7-L5V7","article-title":"Somatic treatment of catatonia","volume":"25","author":"Hawkins JM","year":"1995","unstructured":"HawkinsJM, ArcherKJ, StrakowskiSM, et al. Somatic treatment of catatonia. Int J Psychiatry Med. 1995; 25 (4):345\u2013369.","journal-title":"Int J Psychiatry Med"},{"issue":"3","key":"e_1_3_2_75_2","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1097\/01.WNF.0000221908.56361.C7","article-title":"Lorazepam and diazepam rapidly relieve catatonic features in major depression","volume":"29","author":"Hung YY","year":"2006","unstructured":"HungYY, HuangTL. Lorazepam and diazepam rapidly relieve catatonic features in major depression. Clin Neuropharmacol.2006; 29 (3):144\u2013147.","journal-title":"Clin Neuropharmacol"},{"issue":"3","key":"e_1_3_2_76_2","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/S0006-3223(98)00312-6","article-title":"A double-blind comparison of lorazepam and oxazepam in psychomotor retardation and mutism","volume":"46","author":"Schmider J","year":"1999","unstructured":"SchmiderJ, StandhartH, DeuschleM, et al. A double-blind comparison of lorazepam and oxazepam in psychomotor retardation and mutism. Biol Psychiatry. 1999; 46 (3):437\u2013441.","journal-title":"Biol Psychiatry"},{"issue":"3","key":"e_1_3_2_77_2","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1046\/j.1440-1614.2001.0905i.x","article-title":"Acute severe catatonia in a young woman with chronic schizophrenia responding to parenteral clonazepam","volume":"35","author":"Kumar R.","year":"2001","unstructured":"KumarR. Acute severe catatonia in a young woman with chronic schizophrenia responding to parenteral clonazepam. Aust NZ J Psychiatry. 2001;35 (3):391.","journal-title":"Aust NZ J Psychiatry"},{"key":"e_1_3_2_78_2","unstructured":"American Society of Health System Pharmacists. Lorazepam Injection. Accessed August 22 2022. https:\/\/www.ashp.org\/drug-shortages\/current-shortages\/drug-shortage-detail.aspx?id=87"},{"key":"e_1_3_2_79_2","first-page":"21","article-title":"Electroconvulsive therapy in lorazepam non-responsive catatonia","volume":"45","author":"Girish K","year":"2003","unstructured":"GirishK, GillNS. Electroconvulsive therapy in lorazepam non-responsive catatonia. Indian J Psychiatry. 2003;45 (l):21\u201325.","journal-title":"Indian J Psychiatry"},{"key":"e_1_3_2_80_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.genhosppsych.2017.06.011"},{"issue":"4","key":"e_1_3_2_81_2","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1176\/jnp.2007.19.4.406","article-title":"Review of adjunctive glutamate antagonist therapy in the treatment of catatonic syndromes","volume":"19","author":"Carroll BT","year":"2007","unstructured":"CarrollBT, GoforthHW, ThomasC, et al. Review of adjunctive glutamate antagonist therapy in the treatment of catatonic syndromes. J Neuropsychiatry Clin Neurosci. 2007; 19 (4):406\u2013412.","journal-title":"J Neuropsychiatry Clin Neurosci"},{"issue":"3","key":"e_1_3_2_82_2","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.genhosppsych.2012.01.011","article-title":"Clinical predictors of response to treatment in catatonia","volume":"34","author":"Narayanaswamy JC","year":"2012","unstructured":"NarayanaswamyJC, TibrewalP, ZutshiA, et al. Clinical predictors of response to treatment in catatonia. Gen Hosp Psychiatry. 2012; 34 (3):312\u2013316.","journal-title":"Gen Hosp Psychiatry"},{"key":"e_1_3_2_83_2","doi-asserted-by":"crossref","first-page":"e48","DOI":"10.1176\/appi.neuropsych.11030059","article-title":"Successful treatment of benzodiazepine-resistant malignant catatonia with electroconvulsive therapy","volume":"24","author":"Karacetin G","year":"2012","unstructured":"KaracetinG, BayarR, DemirT. Successful treatment of benzodiazepine-resistant malignant catatonia with electroconvulsive therapy. J Neuropsychiatry Clin Neurosci. 2012;24 (l):e48.","journal-title":"J Neuropsychiatry Clin Neurosci"},{"issue":"3","key":"e_1_3_2_84_2","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1097\/YCT.0b013e3182887a1a","article-title":"Effective treatment of catatonia by combination of benzodiazepine and electroconvulsive therapy","volume":"29","author":"Unal A","year":"2013","unstructured":"UnalA, BulbulF, AlpakG, et al. Effective treatment of catatonia by combination of benzodiazepine and electroconvulsive therapy. J ECT. 2013;29 (3): 206\u2013209.","journal-title":"J ECT"},{"issue":"9","key":"e_1_3_2_85_2","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1007\/s11920-022-01353-0","article-title":"Hermida AP The use of ECT in the elderly\u2014looking beyond depression","volume":"24","author":"Chatham AN","year":"2022","unstructured":"ChathamAN, ShafiH, Hermida AP The use of ECT in the elderly\u2014looking beyond depression. Curr Psychiatry Rep. 2022; 24 (9):451\u2013461.","journal-title":"Curr Psychiatry Rep"},{"key":"e_1_3_2_86_2","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.jaclp.2021.07.010","article-title":"The use of electroconvulsive therapy in neuropsychiatric complications of Coronavirus disease 2019: a systematic literature review and case report","volume":"63","author":"Austgen G","year":"2022","unstructured":"AustgenG, MeyersMS, GordonM, et al. The use of electroconvulsive therapy in neuropsychiatric complications of Coronavirus disease 2019: a systematic literature review and case report. J Acad Consult Liaison Psychiatry. 2022;63 (l):86\u201393.","journal-title":"J Acad Consult Liaison Psychiatry"},{"issue":"2","key":"e_1_3_2_87_2","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.psym.2020.09.007","article-title":"Life-threatening catatonia associated with Coronavirus disease 2019","volume":"62","author":"Deocleciano de Araujo C","year":"2021","unstructured":"Deocleciano deAraujo C, Sch\u00fcttlerLXC, SguarioRM, et al. Life-threatening catatonia associated with Coronavirus disease 2019. J Acad Consult Liaison Psychiatry. 2021; 62 (2):256\u2013257.","journal-title":"J Acad Consult Liaison Psychiatry"},{"key":"e_1_3_2_88_2","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.ajp.2021.102653","article-title":"Electroconvulsive therapy services during COVID-19 pandemic","volume":"59","author":"Surve RM","year":"2021","unstructured":"SurveRM, SinhaP, BaligaSP, et al. Electroconvulsive therapy services during COVID-19 pandemic. Asian J Psychiatr. 2021;59:102\u2013653.","journal-title":"Asian J Psychiatr"},{"key":"e_1_3_2_89_2","article-title":"Maintenance electroconvulsive therapy is an essential medical treatment for patients with catatonia: a COVID-19 related experience","volume":"12","author":"Ghaziuddin N","year":"2021","unstructured":"GhaziuddinN, YaqubT, ShamseddeenW, et al. Maintenance electroconvulsive therapy is an essential medical treatment for patients with catatonia: a COVID-19 related experience. Psychiatry. 2021;12: 670476.","journal-title":"Psychiatry"},{"issue":"3","key":"e_1_3_2_90_2","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1192\/bjb.2020.99","article-title":"Model for ethical triaging of electroconvulsive therapy patients during the COVID-19 pandemic","volume":"45","author":"Tor PC","year":"2021","unstructured":"TorPC, TanJ, LooC Model for ethical triaging of electroconvulsive therapy patients during the COVID-19 pandemic. BJPsych Bull. 2021; 45 (3):175\u2013178.","journal-title":"BJPsych Bull"},{"key":"e_1_3_2_91_2","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/S0033-3182(10)70662-9","article-title":"Treatment of catatoniawithmethylphenidatein an elderly patient with depression","volume":"51","author":"Prowler ML","year":"2010","unstructured":"ProwlerML, WeissD, CaroffSN. Treatment of catatoniawithmethylphenidatein an elderly patient with depression. Psychosomatics. 2010;51 (l):74\u201376.","journal-title":"Psychosomatics"},{"issue":"2","key":"e_1_3_2_92_2","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1176\/jnp.13.2.303","article-title":"Intravenous valproic acid in the treatment of severe catatonia","volume":"13","author":"Kr\u00fcger S","year":"2001","unstructured":"Kr\u00fcgerS, Br\u00e4unigP. Intravenous valproic acid in the treatment of severe catatonia. J Neuropsychiatry Clin Neurosci. 2001; 13 (2):303\u2013304.","journal-title":"J Neuropsychiatry Clin Neurosci"},{"issue":"3","key":"e_1_3_2_93_2","doi-asserted-by":"crossref","DOI":"10.1176\/appi.neuropsych.11080191","article-title":"Combination therapy of zonisamide with aripiprazole on ECT- and benzodiazepine-resistant periodic catatonia","volume":"24","author":"Nakagawa M","year":"2012","unstructured":"NakagawaM, YamamuraS, MotomuraE, et al. Combination therapy of zonisamide with aripiprazole on ECT- and benzodiazepine-resistant periodic catatonia. J Neuropsychiatry Clin Neurosci. 2012;24 (3):e9.","journal-title":"J Neuropsychiatry Clin Neurosci"},{"issue":"6","key":"e_1_3_2_94_2","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.psym.2018.05.012","article-title":"Pediatric catatonia: a case series-based review of presentation, evaluation, and management","volume":"59","author":"Sorg EM","year":"2018","unstructured":"SorgEM, Chaney-CatchpoleM, HazenEP. Pediatric catatonia: a case series-based review of presentation, evaluation, and management. Psychosomatics. 2018; 59 (6):531\u2013538.","journal-title":"Psychosomatics"},{"key":"e_1_3_2_95_2","doi-asserted-by":"crossref","first-page":"2723","DOI":"10.2147\/NDT.S210613","article-title":"Catatonia in down syndrome: systematic approach to diagnosis, treatment and outcome assessment based on a case series of seven patients","volume":"15","author":"Miles JH","year":"2019","unstructured":"MilesJH, TakahashiN, MuckermanJ, et al. Catatonia in down syndrome: systematic approach to diagnosis, treatment and outcome assessment based on a case series of seven patients. Neuropsychiatr Dis Treat. 2019;15:2723\u20132741.","journal-title":"Neuropsychiatr Dis Treat"},{"issue":"4","key":"e_1_3_2_96_2","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1016\/j.pnpbp.2007.01.018","article-title":"Possible anti-catatonie effects of minocycline in patients with schizophrenia","volume":"31","author":"Ahuja N","year":"2007","unstructured":"AhujaN, CarrollBT Possible anti-catatonie effects of minocycline in patients with schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry. 2007;31 (4): 968\u2013969.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"5","key":"e_1_3_2_97_2","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1097\/JCP.0b013e318185a6ee","article-title":"Catatonia and mild neuroleptic malignant syndrome after initiation of long-acting injectable risperidone: case report","volume":"28","author":"Mall GD","year":"2008","unstructured":"MallGD, HakeL, BenjaminAB, et al. Catatonia and mild neuroleptic malignant syndrome after initiation of long-acting injectable risperidone: case report. J Clin Psychopharmacol. 2008; 28 (5):572\u2013573.","journal-title":"J Clin Psychopharmacol"},{"issue":"6","key":"e_1_3_2_98_2","article-title":"Successful treatment of catatonia: a case report and review of treatment","volume":"14","author":"Malone K","year":"2022","unstructured":"MaloneK, SaveenS, StevensCM, et al. Successful treatment of catatonia: a case report and review of treatment. Cureus. 2022;14 (6):e26328.","journal-title":"Cureus"},{"issue":"1","key":"e_1_3_2_99_2","doi-asserted-by":"crossref","DOI":"10.1186\/1744-859X-11-12","article-title":"Treatment of refractory catatonic schizophrenia with low dose aripiprazole","volume":"11","author":"Sasaki T","year":"2012","unstructured":"SasakiT, HashimotoT, NiitsuT, et al. Treatment of refractory catatonic schizophrenia with low dose aripiprazole. Ann Gen Psychiatry. 2012;11 (1):12.","journal-title":"Ann Gen Psychiatry"},{"issue":"5","key":"e_1_3_2_100_2","doi-asserted-by":"crossref","first-page":"473","DOI":"10.2174\/1871527320666210226114238","article-title":"Treatment of catatonia with asenapine in a patient with schizotypal personality disorder, psychotic depression and septic shock from SARSCoV-2: a case report","volume":"20","author":"Fiasch\u00e8 F","year":"2021","unstructured":"Fiasch\u00e8F, AdrianiB, MancinelliI, et al. Treatment of catatonia with asenapine in a patient with schizotypal personality disorder, psychotic depression and septic shock from SARSCoV-2: a case report. CNS Neurol Disord Drug Targets. 2021; 20 (5):473\u2013477.","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"e_1_3_2_101_2","doi-asserted-by":"crossref","first-page":"26","DOI":"10.5334\/tohm.595","article-title":"New-onset movement disorders associated with COVID-19","volume":"11","author":"Brand\u00e3o PRP","year":"2021","unstructured":"Brand\u00e3oPRP, GrippeTC, PereiraDA, et al. New-onset movement disorders associated with COVID-19. Tremor Other Hyperkinet Move (NY). 2021;11:26.","journal-title":"Tremor Other Hyperkinet Move (NY)"},{"issue":"3","key":"e_1_3_2_102_2","doi-asserted-by":"crossref","first-page":"277","DOI":"10.14802\/jmd.21172","article-title":"Catatonia in hospitalized patients with COVID-19: an important clinical finding that should not be missed","volume":"15","author":"Ong TL","year":"2022","unstructured":"OngTL, SapuanS. Catatonia in hospitalized patients with COVID-19: an important clinical finding that should not be missed. J Move Disord. 2022;15 (3): 277\u2013280.","journal-title":"J Move Disord"},{"issue":"1","key":"e_1_3_2_103_2","doi-asserted-by":"crossref","first-page":"179","DOI":"10.24869\/psyd.2022.179","article-title":"Psychotic attack accompanied by catatonia related to COVID-19","volume":"34","author":"\u00c7pil A","year":"2022","unstructured":"\u00c7pilA, KirazS. Psychotic attack accompanied by catatonia related to COVID-19. Psychiatr Danub. 2022; 34 (1):179\u2013180.","journal-title":"Psychiatr Danub"},{"issue":"2","key":"e_1_3_2_104_2","first-page":"454","article-title":"Benzodiazepine-responsive catatonia and delirium in two patients with COVID-19","volume":"69","author":"Jaber VR","year":"2021","unstructured":"JaberVR, SolimanM, FieldJB, et al. Benzodiazepine-responsive catatonia and delirium in two patients with COVID-19. J Invest Med. 2021;69 (2):454.","journal-title":"J Invest Med"},{"issue":"2","key":"e_1_3_2_105_2","article-title":"COVID-19 associated with catatonia and abnormal CSF: a case report","volume":"69","author":"Jaber F","year":"2021","unstructured":"JaberF, AisueniU, TorricoT, et al. COVID-19 associated with catatonia and abnormal CSF: a case report. J Invest Med. 2021;69 (2):477.","journal-title":"J Invest Med"},{"issue":"1","key":"e_1_3_2_106_2","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1097\/01.ccm.0000726852.54146.71","article-title":"241: malignant catatonia possibly precipitated by SARS-CoV-2 infection","volume":"49","author":"Johnson S","year":"2021","unstructured":"JohnsonS, KapoorR, KimYS. 241: malignant catatonia possibly precipitated by SARS-CoV-2 infection. Crit Care Med. 2021;49 (1):107.","journal-title":"Crit Care Med"},{"key":"e_1_3_2_107_2","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.psychres.2020.113555","article-title":"Commentary to \"schizophrenia and COVID-19 delirium,\" an update","volume":"294","author":"Palomar-Ciria N","year":"2020","unstructured":"Palomar-CiriaN, Alonso-\u00c1lvarezD, V\u00e1zquez-Beltr\u00e1nP, et al. Commentary to \"schizophrenia and COVID-19 delirium,\" an update. Psychiatry Res. 2020;294:113\u2013555.","journal-title":"Psychiatry Res"},{"key":"e_1_3_2_108_2","doi-asserted-by":"crossref","first-page":"S334","DOI":"10.4103\/0972-6748.328846","article-title":"COVID-19 presenting with catatonia","volume":"30","author":"Raidurg K","year":"2021","unstructured":"RaidurgK, WadgaonkarG, PanseS, et al. COVID-19 presenting with catatonia. Ind Psychiatry J. 2021;30(Suppl 1):S334\u2013S335.","journal-title":"Ind Psychiatry J"},{"issue":"6","key":"e_1_3_2_109_2","article-title":"COVID-19 associated benzodiazepine-resistant catatonia responds to amantadine","volume":"24","author":"Oh J","year":"2022","unstructured":"OhJ, Amber-MontaK, SahotaPC, et al. COVID-19 associated benzodiazepine-resistant catatonia responds to amantadine. Prim Care Companion CNS Disord. 2022;24 (6):22cr03394.","journal-title":"Prim Care Companion CNS Disord"}],"container-title":["Annals of Clinical Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.12788\/acp.0109","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.12788\/acp.0109","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.12788\/acp.0109","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T17:06:15Z","timestamp":1757610375000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.12788\/acp.0109"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":108,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["10.12788\/acp.0109"],"URL":"https:\/\/doi.org\/10.12788\/acp.0109","relation":{},"ISSN":["1040-1237","1547-3325"],"issn-type":[{"value":"1040-1237","type":"print"},{"value":"1547-3325","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3]]}}}